Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 43 relevant Journals, 38 Conferences, 3 Workshops are presently dedicated exclusively to Bioavailability and Bioequivalence Studies and about 335 articles are being published on bioavailability bioequivalence studies.
Bioavailability Biequivalence studies aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. Bioavailability refers to the extent to which a drug is absorbed into the body and is thus available to act upon the drug's intended target, also known as the "site of action. Bioavailability and Bioequivalence Studies Submitted in New Drug Applications or Investigational New Drug Applications-also known as the NDA BA and BE.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Bioequivalence Conference provides the scope for opportunities to learn progressed by international scientists and academicians. So many symposiums have been conducted and are to be organized all across the globe focusing on the significance of Bioequivalence Innovations, Therapeutic Possibilities and Technological Challenges is going to be organized which will focus on Bioequivalence.
The Bioavailability Bioequivalence Studies aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. Bioavailability refers to the extent to which a drug is absorbed into the body and is thus available to act upon the drug's intended target, also known as the "site of action. Bioavailability and Bioequivalence Studies Submitted in New Drug Applications or Investigational New Drug Applications-also known as the NDA BA and BE.
Play a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners. BA /BE studies has been determined to have practical and public health value for pharmaceutical sponsors, for regulatory agencies, and for patients and practitioners.
The global market for generic drugs was worth $81 billion in 2008, $84 billion in 2009, estimated to be $168.7 billion in 2014. Sales of U.S. generic drugs currently dominate the market with $54 billion for the 2014. Japan’s generic drugs market is expected to have the highest rate of growth among major markets at 12.2%, increasing from $5.4 billion in 2009 to $9.6 billion in 2014.By 2016, it is expected that the value of the total global generics sector will have risen to $358 billion. The North American market is estimated to reach to reach nearly $107 billion in 2016 with an increase of 7.9% compound annual growth rate annual growth rate and Emerging market to reach nearly $115 billion.
International symposium and workshops
List of Best International Conferences:
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising